Boston Scientific Corp (NYSE:BSX) — Market Cap & Net Worth
Market Cap & Net Worth: Boston Scientific Corp (BSX)
Boston Scientific Corp (NYSE:BSX) has a market capitalization of $69.50 Billion ($69.50 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #403 globally and #207 in its home market, demonstrating a -3.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Boston Scientific Corp's stock price $46.76 by its total outstanding shares 1486355179 (1.49 Billion). Review Boston Scientific Corp debt and liabilities to assess the company's total debt and financial obligations.
Boston Scientific Corp Market Cap History: 2015 to 2026
Boston Scientific Corp's market capitalization history from 2015 to 2026. Data shows growth from $27.41 Billion to $69.50 Billion (9.91% CAGR).
Index Memberships
Boston Scientific Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.29 Trillion | 0.31% | #165 of 503 |
Weight: Boston Scientific Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Boston Scientific Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Boston Scientific Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.06x
Boston Scientific Corp's market cap is 7.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
49.11x
Boston Scientific Corp's market cap is 49.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $32.15 Billion | $8.39 Billion | $347.00 Million | 3.83x | 92.65x |
| 2017 | $36.85 Billion | $9.05 Billion | $104.00 Million | 4.07x | 354.30x |
| 2018 | $52.53 Billion | $9.82 Billion | $1.67 Billion | 5.35x | 31.43x |
| 2019 | $67.21 Billion | $10.73 Billion | $4.70 Billion | 6.26x | 14.30x |
| 2020 | $53.43 Billion | $9.91 Billion | -$82.00 Million | 5.39x | N/A |
| 2021 | $63.14 Billion | $11.89 Billion | $1.04 Billion | 5.31x | 60.71x |
| 2022 | $68.77 Billion | $12.68 Billion | $698.00 Million | 5.42x | 98.53x |
| 2023 | $85.93 Billion | $14.24 Billion | $1.59 Billion | 6.03x | 53.94x |
| 2024 | $132.76 Billion | $16.75 Billion | $1.85 Billion | 7.93x | 71.61x |
| 2025 | $141.72 Billion | $20.07 Billion | $2.89 Billion | 7.06x | 49.11x |
Competitor Companies of BSX by Market Capitalization
Companies near Boston Scientific Corp in the global market cap rankings as of June 17, 2026.
Key companies related to Boston Scientific Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Edwards Lifesciences Corp (NYSE:EW): Ranked #550 globally with a market cap of $49.68 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #550 | Edwards Lifesciences Corp | NYSE:EW | $49.68 Billion | $86.28 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Boston Scientific Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Boston Scientific Corp's market cap moved from $27.41 Billion to $ 69.50 Billion, with a yearly change of 9.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $69.50 Billion | -50.96% |
| 2025 | $141.72 Billion | +6.75% |
| 2024 | $132.76 Billion | +54.51% |
| 2023 | $85.93 Billion | +24.94% |
| 2022 | $68.77 Billion | +8.92% |
| 2021 | $63.14 Billion | +18.16% |
| 2020 | $53.43 Billion | -20.50% |
| 2019 | $67.21 Billion | +27.96% |
| 2018 | $52.53 Billion | +42.56% |
| 2017 | $36.85 Billion | +14.61% |
| 2016 | $32.15 Billion | +17.30% |
| 2015 | $27.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Boston Scientific Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $69.50 Billion USD |
| MoneyControl | $69.50 Billion USD |
| MarketWatch | $69.50 Billion USD |
| marketcap.company | $69.50 Billion USD |
| Reuters | $69.50 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyG… Read more